| Document |
Document Title |
|
WO/2022/170960A1 |
Provided in the present invention are a Hypsizigus marmoreus strain, a spore, a fruiting body and the use thereof. The strain is named Finc-B-8031, belongs to Hypsizigus marmoreus, and is deposited in China General Microbiological Cultur...
|
|
WO/2022/173810A1 |
The technology described herein is directed to engineered chemoautotrophic bacteria and methods of producing triacylglycerides. Also described herein are systems or bioreactors comprising said engineered bacteria.
|
|
WO/2022/173143A1 |
The present application relates to a strain of Lactobacillus reuteri, LM1071 (KCCM12650P), and to a composition for alleviating premenstrual syndrome, comprising same. According to one embodiment of the present application, the strain of...
|
|
WO/2022/170689A1 |
Provided are a recombinant leaky strain highly expressing N-glycosylated anti-VEGFR2 monobody, a construction method therefor and use thereof. Efficient extracellular production of N-glycosylated anti-VEGFR2 monobody drug proteins and ca...
|
|
WO/2022/172007A1 |
The invention provides apparatus for implementing a computational system comprising: a colony of live microorganisms and a receptacle in which the microorganisms are able to be stimulated to cause a reaction or to modify their physiology...
|
|
WO/2022/165897A1 |
Provided are Acinetobacter vivianii, a microbial agent thereof and use thereof. The strain is named as Acinetobacter vivianii KJ-1, is deposited at China General Microbiological Culture Collection Center on 17 September 2020, and has a s...
|
|
WO/2022/166433A1 |
Use of Nat1 gene as a screening marker in genetic transformation of oomycetes. The encoding gene Nat1, which can cause resistance to nourseothricin in oomycetes, is used as a screening marker for the screening of transformants during the...
|
|
WO/2022/166398A1 |
A cysteine-rich yeast extract and a preparation method therefor. The preparation method comprises the following steps: (1) fermenting an original strain to obtain yeast milk; (2) carrying out thermal extraction and centrifugation on the ...
|
|
WO/2022/166838A1 |
Provided is a transaminase mutant, having a sequence on which an amino acid mutation takes place on the basis of the sequence as represented by SEQ ID NO: 13. Provided is an enatioselective flipped ω-transaminase ATA-117 mutant. The ami...
|
|
WO/2022/169665A1 |
The present invention is directed to virus -like particles (VLPs) which display immunogenic peptides of Flavivirus non-structural Protein 1 (NS1) derived from Dengue Virus (DENY), immunogenic compositions and vaccines against Flavivirus ...
|
|
WO/2022/166978A1 |
Provided are a genetically engineered probiotic intestinal bacterium, comprising an exogenous expression cassette comprising a nucleotide sequence that encodes acetaldehyde dehydrogenase, wherein the probiotic intestinal bacterium is Esc...
|
|
WO/2022/166459A1 |
A fermentation method for mupirocin, the method comprising performing shake flask seed culture, seed tank culture, fermentation culture, and feed culture. The fermentation method is not only suitable for industrial mass production, but a...
|
|
WO/2022/160360A1 |
Provided are lactobacillus fermentum LF-SCHY34 and an application thereof. The lactobacillus fermentum LF-SCHY34 has been preserved in China General Microbiological Culture Collection Center, with the accession number being CGMCC No. 149...
|
|
WO/2022/160495A1 |
Disclosed is a method for preparing micromolecular galactomannan and galactomannan oligosaccharides by hydrolyzing galactomannan, and a special compound enzyme therefor. The method comprises: carrying out fermentation culture by taking m...
|
|
WO/2022/161914A1 |
The present invention relates to high temperature fermentation of fine chemicals, in particular L-proline and intermediates of L-proline synthesis, and to microorganisms for such fermentation processes. The invention further relates to g...
|
|
WO/2022/160562A1 |
Provided are a lentivirus titer detection primer, a kit and a detection method. The detection kit contains a SIN vector-specific amplification primer, and the primer can only be used to detect the copy number of the lentiviral genome int...
|
|
WO/2022/163649A1 |
The purpose of the present invention is to provide: a vinegar having a higher viscosity compared to conventional vinegars; and a method for producing the same. This vinegar includes a water-soluble polysaccharide, which is PS1 (Glc : Gal...
|
|
WO/2022/161936A1 |
The invention relates to a microbiome-based therapeutic composition comprising an engineered probiotic cell expressing a sulfotransferase and the use of the microbiome-based therapeutic composition in medicine and a therapeutic regimen.
|
|
WO/2022/162266A1 |
The present invention belongs to the technical field of compounds for pest control in crops, more specifically nematicidal compounds isolated from a new strain of the Aspergillus tubingensis species to which the present invention also re...
|
|
WO/2022/160358A1 |
The use of an intestinal microorganism as a marker of bronchopulmonary dysplasia in a premature infant. The intestinal microorganism is one or more of Klebsiella, Prevotella and Streptococcus. An isolated intestinal flora nucleic acid sa...
|
|
WO/2022/165169A1 |
The present disclosure concerns methods of using Pseudomonas chlororaphis subsp. aurantiaca 1214-CHY4 (Accession No. PTA-126941), the cell broth and novel metabolites produced therefrom, that can inhibit the growth of a variety of microb...
|
|
WO/2022/163871A1 |
A wastewater treatment apparatus and method for wastewater containing an organic chromaticity component, the treatment being with an enzyme produced by Bacillus proteolyticus.
|
|
WO/2022/155881A1 |
Provided is a skin source bacteria KBFS1720 having a skin ultraviolet burn repair function, and an application thereof. Also provided is a method for culturing the skin source bacteria.
|
|
WO/2022/157507A1 |
There is described a process for producing at least one of mycoprotein and the components thereof, the process comprising: (i) providing a fermentation media suitable for producing mycoprotein; (ii) fermenting the fermentation media to o...
|
|
WO/2022/157326A1 |
The present disclosure relates to a food product comprising fungi biomass and at least one food additive, the fungi biomass comprising a filamentous mycelium network wherein the at least one food additive is present in an amount of 0.05%...
|
|
WO/2022/156027A1 |
A cell strain for the malignant transformation of human keratinocytes caused by thiodimethylarsenic acid and the use thereof, which belong to the technical field of model construction. By means of the present invention, continuous exposu...
|
|
WO/2022/156055A1 |
Provided is the microcin MccY, wherein the amino acid sequence of the microcin is GGRGHIAEYFSGPITQVAFYG. Further provided are a method for preparing the microcin and the use thereof. Compared with MccJ25 which only has bactericidal activ...
|
|
WO/2022/157556A1 |
Disclosed are Epichloë endophytes that produce bioactive secondary metabolites in symbiotic association with a host plant, particularly a grass host plant. Also disclosed are methods of using these endophytes to confer pest resistance o...
|
|
WO/2022/156402A1 |
Provided are a 1,3/1,4-xylanase MLX1034, a gene encoding same, and an application thereof. The xylanase MLX1034 is isolated from Polaribacter sp. Q13, and has the amino acid sequence as shown in SEQ ID NO. 1, and the nucleotide sequence ...
|
|
WO/2022/158814A1 |
The present invention relates to microalgae of Chlorella genus HS-LZ (Chlorella sp. HS-LZ), which are novel microalgae having the characteristic of being capable of producing zeaxanthin and lutein, and uses thereof.
|
|
WO/2022/151611A1 |
Provided are a cytochrome P450 enzyme mutant and an application thereof. The enzyme activity and anti-Markov oxidation selectivity of P450 derived from a wild-type strain of Bacillus megaterium undergo protein modification by means of di...
|
|
WO/2022/151790A1 |
A Bifidobacterium longum dietary combination for intervening with chronic nephritis and uremia, and the use thereof. The Bifidobacterium longum dietary combination comprises 100 mL of Bifidobacterium longum BL-G301 probiotic milk and 40 ...
|
|
WO/2022/151700A1 |
Provided is a method for promoting growth of E. coli and increasing the yield of a fermented product, which is characterized by knocking out a pilus gene cluster on an E. coli genome, the pilus gene cluster being: yagV-Z, gltF-yhcF, fimA...
|
|
WO/2022/151078A1 |
Provided are an oncolytic virus and an application thereof. The oncolytic virus contains a recombinant nucleic acid. The recombinant nucleic acid comprises: (i) a first nucleic acid fragment for encoding a soluble PD-1 molecule; (ii) a s...
|
|
WO/2022/151669A1 |
Provided is an isolated strain of Lactobacillus amylovorus LAM1345, which is deposited at Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH under an accession number DSM 33510. Also provided are a composition including the isol...
|
|
WO/2022/152036A1 |
Provided are a polynucleotide having promoter activity and use thereof in the production of target compounds. Specifically, provided are a polynucleotide having promoter activity, a transcriptional expression cassette, recombinant expres...
|
|
WO/2022/152914A1 |
The present invention is in the technical field of synthetic biology and metabolic engineering. More particularly, the present invention is in the technical field of cultivation of metabolically engineered cells. The present invention de...
|
|
WO/2022/152615A1 |
The present invention relates to a novel Streptococcus thermophilus strain having improved texturizing properties, compositions comprising said strain as well as fermented products manufactured using said strain.
|
|
WO/2022/148362A1 |
Provided is an engineering probiotic having surface display phenylalanine ammonia-lyase. The engineering probiotic knocks out a gene argR and/or undergoes a gene argA(Y19C) mutation on an Escherichia coli Nissle 1917 genome, and integrat...
|
|
WO/2022/147873A1 |
Provided are a method for preparing an avocado oil-in-water liquid fermented product and the use thereof in cosmetics. The fermented product effectively converts proteins, nucleic acids, polysaccharides, etc. into a small-molecule water-...
|
|
WO/2022/150596A1 |
The present invention relates to processes for preparing linkers that are useful in the conjugation of therapeutic molecules (e.g., cytotoxic agents) with targeting moieties (e.g., proteins, peptides, antibodies, nanoparticles, nucleic a...
|
|
WO/2022/150258A1 |
A method of aerobic microbial processing comprising: culturing microbes comprising a (per)chlorate respiration pathway in a bioreactor in a bioprocess employing microbial respiration of chloroxyanions as a source of oxygen for the biopro...
|
|
WO/2022/147680A1 |
Disclosed in the present invention is a preparation method for meso-2,3-butanediol, comprising the following steps: using renewable biomass as raw material, and producing 2,3-butanediol by means of the fermentation of Klebsiella to obtai...
|
|
WO/2022/149296A1 |
[Problem] To provide a breakthrough method for producing a silk fermentation product using a lactic acid bacterium, whereby it becomes possible to produce a health food material or a cosmetic material that can enhance various functions o...
|
|
WO/2022/148138A1 |
Lactobacillus crispatus Lc31 and Lc83 capable of preventing and/or treating cervical squamous carcinoma. The preservation number of the Lactobacillus crispatus Lc31 is CGMCC No. 21348, and the preservation number of the Lactobacillus cri...
|
|
WO/2022/148008A1 |
Provided are a bacillus subtilis genetically engineered bacterium for producing tagatose and a method for preparing tagatose. The genetically engineered bacterium comprises constructing thermostable α-glucan phosphorylases, thermostable...
|
|
WO/2022/148314A1 |
The present invention relates to the use of an exogenous ATG10S protein in the preparation of an antiviral drug. The exogenous ATG10S is an rhATG10S protein, the coding nucleotide sequence thereof is as shown in SEQ ID NO: 1 or SEQ ID NO...
|
|
WO/2022/148191A1 |
Provided is Wickerhamomyces ciferrii, which has a deposit number of CGMCC No: 19562. Further provided is a method for screening Wickerhamomyces ciferrii, and the use thereof in the production of tetraacetyl phytosphingosine (TAPS).
|
|
WO/2022/149697A1 |
The present invention relates to a composition for controlling anti-obesity activity, containing, as an active ingredient, a Moringa oleifera fermentation product prepared using a novel Monascus purpureus SL1 strain. The Moringa oleifera...
|
|
WO/2022/148351A1 |
The present invention relates to the field of bioengineering and medical chemical production. In particular, provided is a polynucleotide comprising a coding sequence of toluene dioxygenase. Also provided are an expression cassette, a ve...
|
